WILLIAM BYRD: Open Payments
NPI 1083211486 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 24 payments from 9 companies in 2025. Trend: 2023 $28 · 2024 $34 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| ABBVIE INC. | 5 | $93 |
| Almatica Pharma LLC | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Abbott Laboratories | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| Novo Nordisk Inc | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: AIRSUPRA, LOREEV XR, VRAYLAR, XIFAXAN, FREESTYLE LIBRE 3, JARDIANCE, QULIPTA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
